In the light of the ongoing pandemic, we have decided to postpone this year's #BioTarget to early 2⃣0⃣2⃣1⃣
We thank all applicants for your submissions & interest. We will be back soon!
Stay safe and have a successful year ahead.
- The BioTarget Team 🤖✌️
To all our incubator teams - just like we keep saying - don't start with PowerPoint!
20 Lines to Write Before Starting Your Pitch Deck by @fcollective in @thestartup_ https://t.co/iTBvyc4kDI
The grand Pitch Summit will now be held on Oct 15, 2020 right in the heart of the world's leading biotech hub - Boston, MA @CICBoston
Register your interest here: https://t.co/HBTCtSErG2
#Boston#Biotech#Entrepreneurship#DrugDiscovery#BioTarget2020
#COVID19 update: The health and safety of our applicants, panelists & staff is our top priority. We have been monitoring the situation very closely, & have decided to extend the application deadline & postpone the pitch finale in Boston. For more info👇 https://t.co/s3AikX3MXt
Struggling to keep up to date with #COVID-19 updates specific to the #biotech industry?
Our COVID-19 micro-site is updated as soon as announcements are made and contains news specific to our sector.
Visit now👇
https://t.co/DTbYS3OVXl
We are urgently looking to provide business-led innovation solutions to the global disruption caused by #Covid19. This fast response competition will be open until noon on 17 April – https://t.co/aqM5NwtllB @beisgovuk @KTNUK @UKRI_News
Today we announced that the potential treatment for #COVID19 we identified using AI has entered clinical testing. We directed our AI platform to search for treatments from existing medicines that could quickly be moved into clinical trials. Read more: https://t.co/QZtLqQ2H7m
Calling all #drug hunters! Entry is now open for our global business competition 💊
Apply to #BioTarget2020 for your chance to receive up to the value of $100K in #automated experiments to develop new drugs.
Learn more: https://t.co/sn41fu8iWY
#AI#drugdiscovery
“Without trying to diminish the serious and tragic events of the Covid-19 outbreak, it is important to take a longer-term perspective and to look through the current levels of volatility,” says Tom Wright, Director. https://t.co/GKLegTIagj
Strategic Planning In Biotech During A Pandemic Crisis.
This is the Goldilocks moment for many biotechs: not too hot and not too cold. Preserving near term optionality while planning for and adapting to the longer term scenarios.
https://t.co/2OpXgzujTc